AVERSA, Franco
 Distribuzione geografica
Continente #
NA - Nord America 2.366
EU - Europa 1.782
AS - Asia 1.403
SA - Sud America 214
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.782
Nazione #
US - Stati Uniti d'America 2.315
SG - Singapore 624
IE - Irlanda 347
UA - Ucraina 309
SE - Svezia 252
CN - Cina 242
IT - Italia 223
HK - Hong Kong 208
BR - Brasile 187
RU - Federazione Russa 167
FI - Finlandia 143
VN - Vietnam 130
DE - Germania 126
KR - Corea 92
GB - Regno Unito 70
CA - Canada 31
FR - Francia 31
TR - Turchia 25
IN - India 23
PL - Polonia 17
NL - Olanda 16
BE - Belgio 15
AR - Argentina 14
AT - Austria 14
CZ - Repubblica Ceca 14
JP - Giappone 13
CH - Svizzera 11
MX - Messico 11
ZA - Sudafrica 10
BD - Bangladesh 7
IQ - Iraq 7
UZ - Uzbekistan 7
GR - Grecia 6
RO - Romania 5
EC - Ecuador 4
LB - Libano 4
ES - Italia 3
PK - Pakistan 3
PY - Paraguay 3
BG - Bulgaria 2
CO - Colombia 2
CR - Costa Rica 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
LT - Lituania 2
LV - Lettonia 2
NP - Nepal 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
EE - Estonia 1
EU - Europa 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
ID - Indonesia 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
NR - Nauru 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
TN - Tunisia 1
TW - Taiwan 1
YT - Mayotte 1
Totale 5.782
Città #
Singapore 409
Chandler 393
Dublin 345
Hong Kong 208
San Mateo 200
Jacksonville 169
Boardman 136
Ashburn 114
Santa Clara 96
Seoul 86
Perugia 80
Dong Ket 77
Medford 69
Beijing 68
Princeton 68
Ann Arbor 58
Moscow 57
Andover 55
Munich 51
Altamura 50
Helsinki 46
New York 45
Wilmington 44
Lawrence 42
Los Angeles 36
Piscataway 36
Turku 32
Houston 22
Des Moines 21
Saint Petersburg 21
Ho Chi Minh City 20
São Paulo 20
Brooklyn 17
Woodbridge 17
Norwalk 16
Hanoi 15
Shanghai 14
Brussels 13
Izmir 13
San Francisco 13
Tokyo 13
Montreal 12
Auburn Hills 11
San Paolo di Civitate 11
Stockholm 11
Dallas 10
Johannesburg 10
The Dalles 10
Vienna 10
Amsterdam 9
Brno 9
Phoenix 9
Seattle 9
Warsaw 9
Chicago 8
Atlanta 7
Chennai 7
Dearborn 7
Espoo 7
London 7
Nuremberg 7
Rio de Janeiro 7
Bologna 6
Denver 6
Falls Church 6
Orem 6
Ottawa 6
Renton 6
Toronto 6
Boston 5
Columbus 5
Frankfurt am Main 5
Guangzhou 5
Manchester 5
Poplar 5
Rome 5
Tashkent 5
Tianjin 5
Brasília 4
Council Bluffs 4
Falkenstein 4
Hanover 4
Hefei 4
Olomouc 4
Osasco 4
Redmond 4
Redwood City 4
Salerno 4
San Diego 4
Secaucus 4
Wroclaw 4
Ankara 3
Aurora 3
Changsha 3
Charlotte 3
Curitiba 3
Den Haag 3
Foligno 3
Groningen 3
Istanbul 3
Totale 3.658
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 160
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 129
Acute lymphoblastic leukaemia in Noonan syndrome 119
Graft engineering for allogeneic haploidentical stem cell transplantation 113
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 112
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 110
Fourth international workshop on haploidentical transplants, Naples, Italy 109
A multidrug-resistant Pseudomonas aeruginosa isolate from a lethal case of sepsis induces necrosis of human neutrophils 106
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 104
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 101
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 100
"Designed" grafts for HLA-haploidentical stem cell transplantation. 99
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 99
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 98
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 98
Toxoplasma gondii infection in bone marrow transplant recipients: the polymerase chain reaction-blood sample combination in diagnosis and early detection. 95
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 91
Competing risks analysis using R: an easy guide for clinicians 91
Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia. 90
Haploidentical stem cell transplantation for acute leukemia 89
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 89
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 89
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants 89
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 88
Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation. 87
Genetic polymorphisms affecting IDO1 or IDO2 activity differently associate with aspergillosis in humans 86
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite 86
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 83
Totipotent stem cells bearing del(20q) maintain multipotential differentiation in Shwachman Diamond syndrome 83
Mismatched hematopoietic stem cell transplantation in secondary leukemia 82
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 80
PML is required for telomere stability in non-neoplastic human cells 80
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 80
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 80
Pharyngeal microbial signatures are predictive of the risk of fungal pneumonia in hematologic patients 80
Haploidentical transplantation and natural killer cell recognition of missing self. 79
Stem cell mobilization in normal donors. 78
Deploying natural killer cell allotherapy in the setting of HLA-haplotype-mismatched hematopoietic stem cell transplantation 76
Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation 75
New mechanism of lymphoma-induced bone marrow aplasia 74
Infezioni da Cytomegalovirus nel paziente immunodepresso. 72
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation. 70
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL) 68
Outcomes of unrelated cord blood and haploidentical stem cell transplantation in adults with acute leukaemia. 68
Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation 68
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. 68
Improved Outcome With T-Cell–Depleted Bone Marrow Transplantation for Acute Leukemia 68
Natural killer cell allorecognition of missing self in allogenic hematopoietic transplantation :a tool for immunotherapy of leukemia. 66
Full-haplotype mismatched HSCT is a valid option for high-risk acute myeloid leukemia (AML) patients. 65
Stem cell transplantation from full-haplotype mismatched donors in leukemia . 64
Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use 64
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 63
null 63
Outcomes after CD34+ positive immunoselection for haploidentical transplants in high-risk acute leukemia. 60
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 60
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 60
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 59
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 57
The Evolution of T Cell Depleted Haploidentical Transplantation 56
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 55
The haploidentical option for high-risk haematological malignancies. 55
Provision of antifungal immunity and concomitant alloantigen tolerization by conditioned dendritic cells in experimental hematopoietic transplantation. 55
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 53
Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases 53
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 52
Regression Modeling of Competing Risk Using R: An In Depth Guide for Clinicians 52
Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia. 51
Natural killer cells as a therapeutic tool in mismatched transplantation 50
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 49
The role of bronchoalveolar lavage (BAL) in immunocompromised haematological patients. 49
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 48
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 48
null 46
Haploidentical stem cell transplantation in leukemia 44
Hairy cell leukaemia mimicking multiple myeloma 43
T-cell–depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT) 39
Hematopoietic Cell Transplantation from Human Leukocyte Antigen Partially Matched Related Donors 37
null 36
Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunity. 36
null 11
Totale 5.938
Categoria #
all - tutte 27.926
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.926


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021353 0 0 0 0 0 44 50 5 75 31 58 90
2021/2022650 13 165 25 47 19 4 9 190 6 13 73 86
2022/20231.202 81 197 9 102 129 118 2 66 443 11 34 10
2023/2024491 26 60 25 8 8 6 108 12 61 18 73 86
2024/20251.108 26 119 67 59 123 44 69 60 192 58 193 98
2025/20261.201 164 151 101 320 380 85 0 0 0 0 0 0
Totale 5.938